Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [ACTIVE] · [BUSINESS]
2 clusters · 2 sources · 28 days · First seen · Last updated
Pharmaceutical companies sponsoring Formula 1 teams
Overview
Pharmaceutical companies have entered into multi-year agreements to partner with Formula 1 teams.
In October 2026, AbbVie announced it would become the official pharmaceutical partner of the McLaren Mastercard Formula 1 team. Through its ‘Race to Innovate’ program, AbbVie committed to donating $10,000 for every 10 points McLaren earns in the Constructors' Championship to support charities and patient advocacy groups for autoimmune and immune-mediated diseases. This partnership was scheduled to debut at the United States Grand Prix.
In November 2026, Viatris Inc. announced a multi-year agreement to become the official global pharmaceutical partner of the Cadillac Formula 1 Team. This collaboration is set to begin with the 2027 Formula 1 season, aiming to increase brand visibility for Viatris while expanding the commercial ecosystem for the Cadillac team as it prepares for its 2026 debut.
Entities
Viatris Inc. · AbbVie · Fishers, Indiana · McLaren · Formula 1
Timeline
-
[BUSINESS] 2 sourcesViatris named official global pharmaceutical partner of Cadillac F1 Team
Viatris Inc. has signed a multi-year deal to become the official global pharmaceutical partner of the Cadillac Formula 1 Team, starting in 2027.
-
[BUSINESS] 2 sourcesAbbVie and McLaren announce Formula 1 partnership
AbbVie has signed a multi-year deal to become the official pharmaceutical partner of the McLaren Formula 1 team, pledging donations to autoimmune disease charities based on team performance.
Sources
pressreach.com · sportsmintmedia.com